211 related articles for article (PubMed ID: 33794309)
21. Hypoxia contributes to galectin-3 expression in renal carcinoma cells.
Gu X; Meng H; Wang J; Wang R; Cao M; Liu S; Chen H; Xu Y
Eur J Pharmacol; 2021 Jan; 890():173637. PubMed ID: 33065093
[TBL] [Abstract][Full Text] [Related]
22. Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma.
Demirović A; Tomas D; Tomić K; Spajić B; Ibukić A; Cupić H; Krušlin B
Scand J Urol; 2014 Feb; 48(1):34-40. PubMed ID: 24256617
[TBL] [Abstract][Full Text] [Related]
23. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of the very low-density lipoprotein receptor mediates lipid accumulation in clear-cell renal cell carcinoma.
Sundelin JP; Ståhlman M; Lundqvist A; Levin M; Parini P; Johansson ME; Borén J
PLoS One; 2012; 7(11):e48694. PubMed ID: 23185271
[TBL] [Abstract][Full Text] [Related]
25. ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma.
Carew JS; Esquivel JA; Espitia CM; Schultes CM; Mülbaier M; Lewis JD; Janssen B; Giles FJ; Nawrocki ST
PLoS One; 2012; 7(1):e31120. PubMed ID: 22295124
[TBL] [Abstract][Full Text] [Related]
26. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability.
Chen X; Yong H; Chen M; Deng C; Wang P; Chu S; Li M; Hou P; Zheng J; Li Z; Bai J
J Exp Clin Cancer Res; 2023 Jan; 42(1):34. PubMed ID: 36694250
[TBL] [Abstract][Full Text] [Related]
27. Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.
Joshi S; Singh AR; Durden DL
Cancer Chemother Pharmacol; 2015 Mar; 75(3):595-608. PubMed ID: 25578041
[TBL] [Abstract][Full Text] [Related]
28. Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells.
David JM; Owens TA; Barwe SP; Rajasekaran AK
Mol Cancer Ther; 2013 Nov; 12(11):2296-307. PubMed ID: 24006494
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
30. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
[TBL] [Abstract][Full Text] [Related]
31. VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.
Lessi F; Mazzanti CM; Tomei S; Di Cristofano C; Minervini A; Menicagli M; Apollo A; Masieri L; Collecchi P; Minervini R; Carini M; Bevilacqua G
Med Oncol; 2014 Mar; 31(3):840. PubMed ID: 24446253
[TBL] [Abstract][Full Text] [Related]
32. Silencing of HIF-1alpha suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis.
Xu K; Ding Q; Fang Z; Zheng J; Gao P; Lu Y; Zhang Y
Cancer Gene Ther; 2010 Mar; 17(3):212-22. PubMed ID: 19816521
[TBL] [Abstract][Full Text] [Related]
33. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
34. Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma.
Wen YC; Lin YW; Chu CY; Yang YC; Yang SF; Liu YF; Hsiao M; Lee WJ; Chien MH
J Pineal Res; 2020 Sep; 69(2):e12668. PubMed ID: 32408377
[TBL] [Abstract][Full Text] [Related]
35. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
[TBL] [Abstract][Full Text] [Related]
36. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
[TBL] [Abstract][Full Text] [Related]
37. SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155/HIF-1α signaling.
Wang J; Zou Y; Du B; Li W; Yu G; Li L; Zhou L; Gu X; Song S; Liu Y; Zhou W; Xu B; Wang Z
Cell Death Dis; 2021 Jul; 12(7):672. PubMed ID: 34218253
[TBL] [Abstract][Full Text] [Related]
38. LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma.
Wang K; Xu T; Ruan H; Xiao H; Liu J; Song Z; Cao Q; Bao L; Liu D; Wang C; Cheng G; Liang H; Chen Z; Yang H; Chen K; Zhang X
Cell Death Dis; 2019 Feb; 10(3):159. PubMed ID: 30770793
[TBL] [Abstract][Full Text] [Related]
39. CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.
Biswas S; Charlesworth PJ; Turner GD; Leek R; Thamboo PT; Campo L; Turley H; Dildey P; Protheroe A; Cranston D; Gatter KC; Pezzella F; Harris AL
Carcinogenesis; 2012 Sep; 33(9):1717-25. PubMed ID: 22777959
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers.
Ding Q; He D; He K; Zhang Q; Tang M; Dai J; Lv H; Wang X; Xiang G; Yu H
Tumour Biol; 2015 Nov; 36(11):8761-72. PubMed ID: 26055142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
